- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Organovo Holdings Inc
+ Add to WatchlistONVO:US
4.0000 USD 0.0500 1.23%As of 20:10:00 ET on 06/18/2013.
Snapshot for Organovo Holdings Inc (ONVO)
| Open: | 4.0250 | Day's Range: | 3.8800 - 4.0400 | Volume: | 277,519 |
|---|---|---|---|---|---|
| Previous Close: | 4.0500 | 52wk Range: | 1.4900 - 10.9000 | 1-Yr Rtn: | -58.55% |
Key Statistics for ONVO
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -1.5200 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 258.75 |
| Shares Outstanding (M) | 64.69 |
| 30 Day Average Volume | 421,893 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 148.5271 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ONVO
Company Profile & Key Executives for ONVO
Organovo Holdings, Inc. is a biology company. The Company focuses on bioprinting technology and creating tissue for research and medical applications.
| Keith MurphyChairman/President/CEO | Barry D MichaelsCFO/Secretary |
| Eric Michael DavidChief Strategy Officer/Co-Founder | Sharon Collins PresnellExec VP:Rsch & Dev/CTO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ONVO News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page